Search - tctmd.com

Displaying 341 - 360 of 628

Sort: Relevancy | Date

Presentation LAA 2017

Patient Selection and Outcomes of PFO Closure in Idiopathic Stroke: Lessons From RESPECT and Worldwide Registries

Presenter: David E. Thaler

July 22, 2017

Presentation LAA 2017

LAA and PFO Closure - Interventional Prevention of Cardioembolic Stroke: A Technique-Oriented Course

Presenter: Apostolos Tzikas

July 22, 2017

Podcast

Episode 15: BRS, Left Main PCI, PFO Closure, and More

July 19, 2017

Podcast TCTMD Talking Points

Episode 25: RESPECT - Final Long-term Outcomes of PFO Closure for Cryptogenic Stroke

July 12, 2017

Presentation

CLOSE: Closure of PFO, Oral Anticoagulants, or Antiplatelet Therapy to Prevent Stroke Recurrence

May 24, 2017

Presentation

PFO Closure in the Gore REDUCE Clinical Trial

May 24, 2017

News Daily News

Two New Trials Buoy Outlook for PFO Closure in Patients With Cryptogenic Stroke

Todd Neale

May 24, 2017

Presentation SIF 2017

PFO Closure for Cryptogenic Stroke Choose your Patients Well

Presenter: James A. Goldstein

March 09, 2017

News Opinion Conversations in Cardiology

Conversations in Cardiology: For Fellows, How Much Structural Heart Disease Training Is Enough?

February 27, 2017

News Daily News

NeuroARC Proposes New Standards for Assessing Neurologic Damage in CV Clinical Trials

Caitlin E. Cox

February 07, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular News and Features for 2016

Shelley Wood

December 29, 2016

News Daily News

PFO and Migraine? New Study Zeros in on Atrial Septal Aneurysms

Shelley Wood

December 08, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2016

Shelley Wood

November 30, 2016

Presentation TCT 2016

Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do?

Presenter: Eustaquio Maria Onorato, Richard Smalling, Robert J. Sommer

November 01, 2016

Presentation TCT 2016

The REDUCE Trial: Will It Be Positive and What Will We Learn?

Presenter: Eustaquio Maria Onorato, Richard Smalling, John F. Rhodes

November 01, 2016

Presentation TCT 2016

What Should Be the Next Series of Clinical Trials in PFO Closure?

Presenter: Eustaquio Maria Onorato, Richard Smalling, John D. Carroll

November 01, 2016

Presentation TCT 2016

The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed?

Presenter: Eustaquio Maria Onorato, Richard Smalling, David E. Thaler

November 01, 2016

Presentation TCT 2016

Anticipating FDA approval of the Amplatzer PFO Occluder: Indications, Rational Dispersion of Technology, and Post-Approval Studies

Presenter: Eustaquio Maria Onorato, Richard Smalling

November 01, 2016

Presentation TCT 2016

Building a Successful PFO Closure Program

Presenter: John D. Carroll, Christian Spies

November 01, 2016

Presentation TCT 2016

Available Devices/Techniques for Closure of PFO

Presenter: John D. Carroll, Christian Spies, Michael J. Mullen

November 01, 2016

Advertisement

Patient Selection and Outcomes of PFO Closure in Idiopathic Stroke: Lessons From RESPECT and Worldwide Registries

LAA and PFO Closure - Interventional Prevention of Cardioembolic Stroke: A Technique-Oriented Course

Episode 15: BRS, Left Main PCI, PFO Closure, and More

Episode 25: RESPECT - Final Long-term Outcomes of PFO Closure for Cryptogenic Stroke

CLOSE: Closure of PFO, Oral Anticoagulants, or Antiplatelet Therapy to Prevent Stroke Recurrence

PFO Closure in the Gore REDUCE Clinical Trial

Two New Trials Buoy Outlook for PFO Closure in Patients With Cryptogenic Stroke

PFO Closure for Cryptogenic Stroke Choose your Patients Well

Conversations in Cardiology: For Fellows, How Much Structural Heart Disease Training Is Enough?

NeuroARC Proposes New Standards for Assessing Neurologic Damage in CV Clinical Trials

TCTMD’s Top 10 Most Popular News and Features for 2016

PFO and Migraine? New Study Zeros in on Atrial Septal Aneurysms

TCTMD’s Top 10 Most Popular Stories for November 2016

Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do?

The REDUCE Trial: Will It Be Positive and What Will We Learn?

What Should Be the Next Series of Clinical Trials in PFO Closure?

The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed?

Anticipating FDA approval of the Amplatzer PFO Occluder: Indications, Rational Dispersion of Technology, and Post-Approval Studies

Building a Successful PFO Closure Program

Available Devices/Techniques for Closure of PFO

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content